NYSE
STEM
Last Price
US $6.61
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Stem, Inc. cash flow to debt ratio of 2.11% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Stem, Inc.'s free cash flow has increased -114.17% from $-48.42M last year to $6.86M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Stem, Inc.'s debt to equity ratio is -1.24, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
Stem, Inc.'s debt to equity ratio is -1.24, signaling that the company spent its equity and risk bankruptcy.
Financial stability - Net debt/EBITDA.
Stem, Inc. has a net debt to EBITDA ratio of 1.33x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial risk - ICR.
Stem, Inc.'s interest coverage ratio is -1.86, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
Stem, Inc.'s profit margin has increased (-115.94%) in the last year from -590.67% to 94.16%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Stem, Inc.'s short-term liabilities of $110.56M exceed its short-term assets of $100.09M, signaling financial risk
Increasing performance - ROA.
Stem, Inc.'s return on assets of 51.03% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
Stem, Inc.'s return on equity of -59.59%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Stem, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Stem, Inc. had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Increasing performance - Free cash flow.
Stem, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Stem, Inc. has a free cash flow yield of 11.59%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Stem, Inc.'s yearly earnings has increased -116.13% since last year from $-854.01M to $137.76M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Stem, Inc.'s yearly revenue has increased 8.08% since last year from $144.58M to $156.27M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -27.70% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Stem, Inc.'s 3-year revenue CAGR of -24.49% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Stem, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Stem, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Stem, Inc. has insufficient data to evaluate this check.
Undervalued - Earnings yield.
Stem, Inc. has an earnings yield of 255.49%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Stem, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Stem, Inc. has an EV/EBITDA ratio of 1.62x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Stem, Inc. has a PEG-ratio under 1 which is considered undervalued
Overvalued - P/B ratio.
Stem, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
Stem, Inc. has a price-to-sales ratio of 0.37x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-59.59%
Return on equity
ROIC: -27.70%
Valuation History
0.40X
Price to Earnings
EV/EBITDA: 1.6X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $6.61
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.